Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACI-2 trial in lacunar stroke
ISRCTN14911850Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cilostazol and isosorbide mononitrate in lacunar infarct and Cerebral Small Vessel Disease (CSVD) (4 arms), sponsored by University of Edinburgh. Primary endpoint: Feasibility of future Phase III trial. Started Jan 2018; status: completed.
02
Drugs
cilostazolisosorbide mononitrate
03
Conditions
lacunar infarctCerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on ISRCTN14911850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14911850.